Creative Details

Quality Score: 4/10

The advertisement promotes MAVENCLAD (cladribine) tablets as an effective treatment for relapsing forms of multiple sclerosis, highlighting its proven efficacy and safety information.

Creative Information

CID:aa295708-68e6-48d9-a560-39671fcbae66
CRID:82_5557-818635
Domain:mavenclad.com
Seat:PP
Size:300x600
Bid:$1.74
Timestamp:11/4/2025, 4:59:11 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/4/2025, 7:11:50 PM6.94s
    adomain_analysissuccess11/4/2025, 7:53:22 PM3.67s
    adomain_capturesuccess11/4/2025, 7:52:54 PM0.08s
    ad_rendersuccess11/4/2025, 7:11:43 PM25.08s
    brand_mappingsuccess11/4/2025, 7:11:36 PM4.71s

    Analysis Results

    Ad Format: banner

    Brands: MAVENCLAD

    Sensitive:Pharmaceutical Products
    Quality:Adomain not match landing page domain
    Size:300x600
    Data Transferred:1480.79 KB
    Render Time:9.53 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Society (IAB14)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Landing Page:
    https://ma2-tr.contextweb.com/bh/ct2?i=ywcATZlHS86...
    Domain:ma2-tr.contextweb.com
    Brand:
    Internet Archive
    Total Ad Size:1480.92 KB
    Requests Made:
    URLSize (KB)
    https://cdn.doubleverify.com/dvbm.js523.96
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js222.95
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N30602.620333PULSEPOINT4/B32900492.410685997;dc_ver=106.314;sz=300x600;u_sd=1;gdpr_consent=AUDIT;nel=1;kw=2252548;dc_adk=3706686476;ord=5gqlwq;click=https%3A%2F%2Fma2-tr.contextweb.com%2Fbh%2Fct2%3Fi%3DywcATZlHS86N~a%3D20bad28fed252011126da9b8836cb6045410ba1e~agi%3D221914~ts%3Ds6YkQ5bIZS__0nlTogDYgZpmdAT9lkUB~es%3D2~c%3D2252548~p%3D562001~pu%3Dhttps%253A%252F%252Fwww.omnicalculator.com%252Ffinance%252Fmargin~s%3Dcontextweb.com~dt%3D2~u%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=EStl'xj6F6;gcsr=m;stc=1;chaa=1;sttr=113;prcl=s100.90
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://cdnjs.cloudflare.com/ajax/libs/overlayscrollbars/1.12.0/js/OverlayScrollbars.min.js52.26
    https://ep1.adtrafficquality.google/bg/o8qSqbgXbUyLo_VmtgPLKSrrU1j3v_WfJclX0NejYG8.js52.06
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74
    https://c.evidon.com/geo/ba.js?r23112142.46
    https://choices.truste.com/ca?pid=pulsepoint01&aid=pulsepoint01&cid=24368&c=ywcATZlHS86N&w=300&h=600&plc=tr35.24

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2Creative Screenshot 3